Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.24B P/E 40.55 EPS this Y 32.20% Ern Qtrly Grth 41.50%
Income 163.5M Forward P/E 50.85 EPS next Y 18.10% 50D Avg Chg -10.00%
Sales 787.97M PEG 2.63 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 16.17 EPS next 5Y 25.00% 52W High Chg -21.00%
Recommedations 3.00 Quick Ratio 12.50 Shares Outstanding 37.54M 52W Low Chg 46.00%
Insider Own 1.20% ROA 8.68% Shares Float 37.48M Beta 0.88
Inst Own 98.73% ROE 24.73% Shares Shorted/Prior 1.83M/1.47M Price 252.23
Gross Margin 86.99% Profit Margin 20.75% Avg. Volume 563,770 Target Price 324.27
Oper. Margin 19.38% Earnings Date Aug 5 Volume 408,157 Change -2.90%
About ShockWave Medical, Inc.

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California. As of May 31, 2024, Shockwave Medical, Inc. operates as a subsidiary of Johnson & Johnson.

SWAV Chatroom

User Image gba Posted - 10/26/24

$ICCM AH case is the reason I keep adding beside crazy product. Nothing happen in ISRAEL that related to this. Pure manipulation to take big stake and than to take it up. no other reason. The technology is promising and I beleive it will end like $SWAV, they just need the FDA approve. Big pharma will buy it at 20 level.

User Image dick_dasterdly Posted - 10/23/24

$VKTX Look.. We are not $SWAV aka Shockwave Medical. I owned them and waited. Until they went parabolic and got bought. We're right there though. We have that same smell. You know...THAT SMELL. You either recognize it , or you don't. If ya do though.. Congrats ! You have hands of steel. We're the next best thing. Especially for the foreseeable future. That's why our SP is what it is. When the whales are behind ya.. that's a good thing. We're not your average everyday bio. Hello.!??? We have a full clip. Locked and Loaded. We're stacked. Our updates/announcements come out in rapid fire. We have already hit the ground running. We are the game- changer. Accept it. Get used to it.

User Image Jonjon1234 Posted - 4 weeks ago

@TriGuy8542 @techinvestoor I learned my lesson with $SWAV. At one time it was my largest position and I had to trim. I am disciplined enough now to sell around core positions, but always maintain a decent position in any company that has tremendous long-term potential.

User Image TJmaximus Posted - 09/26/24

$SWAV https://x.com/shockwaveivl/status/1834626925639168246?s=46&t=895_nf_tnQeu2vGeIioosw

User Image Maverick11 Posted - 2 months ago

$VKTX Here I was in Jan calling the $25-125 move and takeout in $SWAVhttps://stocktwits.com/Maverick11/message/557125162 $VKTX has same imminent feel. MORESO. $VKTX holding I have dwarfs what I had and the 2x I made there… $VKTX $RKLB and the small cap multi baggers. Mav

User Image Maverick11 Posted - 2 months ago

$VKTX “This could get very interesting today”… https://stocktwits.com/Maverick11/message/585682939 - reminds me of when there was this lingering view that $SWAV was going to get bought out. I was in the name. We knew there were suitors. There were shorts/deniers… it took gut and perseverance… and then BOOM. VKTX has same look and feel. Mav

User Image Maverick11 Posted - 08/25/24

@GriZlyBeAr @solarking It feels more tangible - very quiet from the co; Matt Higgins from RSE hammering the table on $VKTX, stock pops on Monday from $58 to $67, the massive call volume more so than usual - hearing more and more $MRK as the name. Reminds me of $SWAV which I was in - $JNJ kept being mentioned and next thing you know it came to fruition. Would not surprise any minute we have word…

User Image MaverikIT Posted - 5 months ago

@net0trader @IsabellaDC @DonCorleone77 @Wigglyick @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski @CycleTrade $SILK & $SWAV IPOed around same time. SWAV shocked the shorts while SILK stagnanted - may be their time now

User Image gerrard87 Posted - 5 months ago

@Hawaiianinvesta biggest point: excess executive fat. The company has too much exec fat on stock compensation(this is not a Mag 7 stock!). Other points: 1. No Shareholder is here in the money (even with 90% institutional ownership). Check longterm downtrend, would not bet for a turnover in 12-24 months here with this managment. 2. Insider selling (no insider buying even at this level) 3. competition (not like $SWAV or $ABMD) 4. no sustained and increased positve net profit and EPS 5. Oustanding shares growing 6. single digits growth coming (valuation high at this point)

User Image AlphaRR Posted - 5 months ago

$ASXC seriously , time to sell If the deal doesn't go through , stock is going to zero . The only money left is ks's It's bankrupt, this is a fact Take your 33 cents and move on If u vote no , it's zero as ks will ask for their money back and you can't pay it They will end up with the ip anyway So might as well take take the money Whenever a deal is close I always suggest taking the money when stock Price is close to deal price cause sometimes they fall apart and it's awful Look what happened to $IRBT Dumped all my $SWAV as that is close to deal price

User Image pleaseletmeretireearly Posted - 5 months ago

$SWAV did Johnson and Johnson buy us out. I had 5 shares in my Roth that I bought couple years before Covid. Now I have almost 2 grand cash in my cash account? What to buy, can I make this a double please!!

User Image dick_dasterdly Posted - 5 months ago

@Options_Shark1984 I've been fortunate. I've been able to luck up on a couple more that's help me along the way. Shout out to $SWAV and $CMG . Whew ..

User Image First_10Trillion_Google Posted - 5 months ago

$SWAV This ticker closed in the exchange as JNJ brought.

User Image nvdamoney Posted - 5 months ago

$SWAV dreams of $600 never occurred

User Image DonCorleone77 Posted - 5 months ago

$SRPT $SWAV $JNJ Sarepta to replace ShockWave Medical in S&P 400 at open on 6/3 Johnson & Johnson (JNJ) is acquiring Shockwave Medical (SWAV) in a deal expected to be completed soon pending final closing conditions.

User Image TJmaximus Posted - 05/31/24

$SWAV https://x.com/shockwaveivl/status/1796553608743555331?s=61&t=Y1FWAT9d9fsiZT7JJWB3Mg

User Image TJmaximus Posted - 05/31/24

$SWAV @Stocktwits please remove ticker as the symbol is no longer trading... CHA CHING!!!!!

User Image tradethehalt Posted - 05/30/24

$SWAV trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $334.80 Vol: 4.70M.

User Image HaltTradeAlert Posted - 05/30/24

$SWAV Halt Time: 19:50:00 Issue Symbol: SWAV Reason Code: T12 Last Price: $334.75 Market Cap: $12567686625 Volume: 3947054.0 Relative Volume: 2.79 Shares Float: 37543500 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

User Image StockInvest_us Posted - 05/30/24

Signal alert: $SWAV - Oversold Trend Short (Undervalued) https://stockinvest.us/l/s7Wsm2FfI1

User Image DonCorleone77 Posted - 05/29/24

$SRPT $SWAV $JNJ Sarepta to replace ShockWave Medical in S&P 400 at open on 6/3 Johnson & Johnson (JNJ) is acquiring Shockwave Medical (SWAV) in a deal expected to be completed soon pending final closing conditions.

User Image StockInvest_us Posted - 05/28/24

Signal alert: $SWAV - Oversold Trend Short (Undervalued) https://stockinvest.us/l/YZGnhKW1jb

User Image Maverick11 Posted - 05/24/24

@HammerofGods Try and get in “early” with some size/conviction. Stay w/ the name. I’ve been there in $SMCI $VKTX $ARM $SWAV. $OKLO mixed success (so far)… requires trading around which I don’t love. It will be a big success.

User Image TJmaximus Posted - 6 months ago

$SWAV Bought shares on day of announcement and just cashed those out for a 3% return after a 6 week hold, what would that be annualized @Pika_Capital?

User Image TJmaximus Posted - 6 months ago

$SWAV selling the last of the bunch AH...

User Image DonCorleone77 Posted - 6 months ago

$SWAV $JNJ ShockWave Medical says HSR Act waiting period expired on May 20 In a regulatory filing, Shockwave Medical stated: "As previously announced, on April 4, 2024, Shockwave Medical entered into an Agreement and Plan of Merger with Johnson & Johnson, a New Jersey corporation, and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson, providing for the merger of Merger Sub with and into Shockwave, with Shockwave surviving the Merger as a wholly owned subsidiary of Johnson & Johnson. The closing of the Merger is conditioned upon, among other things, the expiration or termination of the waiting period applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Shockwave and Johnson & Johnson each made the necessary filings under the HSR Act with the Antitrust Division of the U.S. Department of Justice and the U.S. Federal Trade Commission on April 18, 2024. The required waiting period under the HSR Act with respect to the Merger expired at 11:59 p.m., Eastern Time on May 20, 2024. The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the Merger." The company notes that the closing of the merger remains subject to the satisfaction or waiver of other customary closing conditions and as previously announced, Shockwave has scheduled the special meeting of stockholders for May 29 to vote on adoption of the merger agreement.

User Image Mergerbrief Posted - 6 months ago

$SWAV $JNJ - HSR Possibly Expires MergerBrief.com

User Image bbbb_dddd Posted - 6 months ago

@People_Who_Hate_Shorts $SWAV lol.

User Image StockInvest_us Posted - 6 months ago

Signal alert: $SWAV - Oversold Trend Short (Undervalued) https://stockinvest.us/l/BzTltKshGc

User Image El_Hoov_2 Posted - 6 months ago

@RocketThief $swav has a larger addressable market and less risk to GLP-1 disruption. Also higher gross margin and lower marketing costs.

Analyst Ratings
CL King Neutral Apr 8, 24
Leerink Partners Market Perform Apr 8, 24
Deutsche Bank Hold Apr 8, 24
Morgan Stanley Equal-Weight Apr 8, 24
Canaccord Genuity Hold Apr 5, 24
Needham Hold Apr 5, 24
Wolfe Research Peer Perform Apr 5, 24
Piper Sandler Overweight Apr 2, 24
CL King Buy Mar 27, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 05 Sell 230.7 3,229 744,930 21,005 02/06/24
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 229.92 3,406 783,108 27,732 02/02/24
Zacharias Isaac President, CCO President, CCO Jan 26 Sell 224.69 4,000 898,760 63,920 01/29/24
Zacharias Isaac President, CCO President, CCO Jan 26 Option 6.71 4,000 26,840 67,920 01/29/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Sell 217.93 10,000 2,179,300 141,057 01/18/24
Godshall Douglas Evan President & CEO President & CEO Jan 16 Option 3.42 10,000 34,200 151,057 01/18/24
Zacharias Isaac President, CCO President, CCO Jan 12 Option 5.37 17,921 96,236 63,920 01/17/24
WATKINS FRANK T Director Director Jan 08 Sell 198.09 2,000 396,180 4,532 01/10/24
WATKINS FRANK T Director Director Jan 08 Option 3.42 2,000 6,840 6,532 01/10/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Sell 200.05 10,000 2,000,500 141,057 01/08/24
Godshall Douglas Evan President & CEO President & CEO Jan 05 Option 3.42 10,000 34,200 151,057 01/08/24
WATKINS FRANK T Director Director Jun 20 Option 3.416 3,000 10,248 4,532 01/04/24
Zacharias Isaac President, CCO President, CCO Dec 26 Sell 192.5 4,000 770,000 41,606 12/28/23
Zacharias Isaac President, CCO President, CCO Dec 26 Option 6.71 3,458 23,203 45,606 12/28/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Sell 188.79 5,000 943,950 141,057 12/18/23
Godshall Douglas Evan President & CEO President & CEO Dec 15 Option 3.42 5,000 17,100 146,057 12/18/23
PUCKETT DAN Chief Financial Offi.. Chief Financial Officer Dec 08 Sell 173.88 200 34,776 28,784 12/11/23
Phung Trinh VP, Finance VP, Finance Dec 07 Sell 171.63 203 34,841 29,037 12/08/23
Zacharias Isaac President, CCO President, CCO Nov 27 Sell 173.58 4,000 694,320 43,868 11/28/23
Zacharias Isaac President, CCO President, CCO Nov 27 Option 6.71 3,777 25,344 47,868 11/28/23
WATKINS FRANK T Director Director Nov 20 Sell 173.11 3,000 519,330 1,532 11/21/23
WATKINS FRANK T Director Director Nov 20 Option 3.42 3,000 10,260 4,532 11/21/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Sell 174.38 5,000 871,900 136,057 11/17/23
Godshall Douglas Evan President & CEO President & CEO Nov 15 Option 3.42 5,000 17,100 141,057 11/17/23
Phung Trinh VP, Finance VP, Finance Apr 26 Option 3.42 2,400 8,208 31,095 11/03/23
Zacharias Isaac President, CCO President, CCO Oct 26 Sell 210.25 4,000 841,000 44,316 10/30/23
Zacharias Isaac President, CCO President, CCO Oct 26 Option 6.71 411 2,758 48,316 10/30/23
WATKINS FRANK T Director Director Oct 20 Sell 203.14 3,000 609,420 1,532 10/23/23
WATKINS FRANK T Director Director Oct 20 Option 3.42 3,000 10,260 4,532 10/23/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Sell 199.71 10,000 1,997,100 141,649 10/17/23
Godshall Douglas Evan President & CEO President & CEO Oct 16 Option 3.42 10,000 34,200 151,649 10/17/23
Zacharias Isaac President, CCO President, CCO Sep 26 Sell 192.12 4,000 768,480 47,905 09/27/23
WATKINS FRANK T Director Director Sep 20 Sell 209.23 3,000 627,690 1,532 09/21/23
WATKINS FRANK T Director Director Sep 20 Option 3.42 3,000 10,260 4,532 09/21/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Sell 212.62 10,000 2,126,200 141,649 09/19/23
Godshall Douglas Evan President & CEO President & CEO Sep 15 Option 3.42 10,000 34,200 151,649 09/19/23
Phung Trinh VP, Finance VP, Finance Aug 29 Option 3.416 5,000 17,080 25,986 08/31/23
Zacharias Isaac President, CCO President, CCO Aug 25 Sell 204.98 4,000 819,920 52,446 08/29/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Sell 212.95 10,000 2,129,500 141,649 08/25/23
Godshall Douglas Evan President & CEO President & CEO Aug 24 Option 3.42 10,000 34,200 151,649 08/25/23
FRANCIS LAURA Director Director Aug 22 Sell 220.97 497 109,822 3,054 08/23/23
WATKINS FRANK T Director Director Aug 21 Sell 218.97 3,000 656,910 1,532 08/22/23
WATKINS FRANK T Director Director Aug 21 Option 3.42 3,000 10,260 4,532 08/22/23
Toyloy Sara Director Director Aug 15 Sell 223.64 100 22,364 3,673 08/16/23
Zacharias Isaac President, CCO President, CCO Jul 26 Sell 268.06 4,000 1,072,240 56,678 07/27/23
WATKINS FRANK T Director Director Jul 20 Sell 267.11 3,000 801,330 1,532 07/21/23
WATKINS FRANK T Director Director Jul 20 Option 3.42 3,000 10,260 4,532 07/21/23
Papiernik Antoine Director Director Jul 05 Option 17.00 17,381 295,477 22,662 07/06/23
Zacharias Isaac President, CCO President, CCO Jun 26 Sell 291.84 4,000 1,167,360 60,678 06/26/23
Phung Trinh VP, Finance VP, Finance Jun 22 Sell 295.91 62 18,346 21,101 06/26/23